Surgical management, DNA content, and patient survival in adrenal cortical carcinoma.

Lee, J E; Berger, D H; el-Naggar, A K; Hickey, R C; Vassilopoulou-Sellin, R; Gagel, R F; Burgess, M A; Evans, D B

Lee, J E; Berger, D H; el-Naggar, A K; Hickey, R C; Vassilopoulou-Sellin, R; Gagel, R F; Burgess, M A; Evans, D B.

Affiliation

Lee JE; Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

Surgery ; 118(6): 1090-8, 1995 Dec.

Article in En | MEDLINE | ID: mdl-7491528

Subject(s)

Adrenal Cortex Neoplasms/surgery; Carcinoma/surgery; DNA, Neoplasm/analysis; Adenoma/genetics; Adenoma/mortality; Adenoma/surgery; Adolescent; Adrenal Cortex Neoplasms/genetics; Adrenal Cortex Neoplasms/mortality; Adult; Aged; Aneuploidy; Carcinoma/genetics; Carcinoma/mortality; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Mitotane/therapeutic use; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Survival Rate

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: DNA, Neoplasm / Carcinoma / Adrenal Cortex Neoplasms Type of study: Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Surgery Year: 1995 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links